packageAcalabrutinib

acalabrutinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Acalabrutinib is a Bruton's tyrosine kinase inhibitor used to treat mantle cell lymphoma and chronic lymphocytic leukemia. It is an approved medicine, also still under investigation for other uses.

Summary written by glm-5.3-flash from Wikidata Q23668732 and the WHO ATC classification; not checked by a person.

name:acalabrutinib
ATC codes:L01EL02
DrugBank:DB11703
PubChem CID:71226662
ChEBI:167707
Wikidata:Q23668732
formula:C26H23N7O2
molar mass:465.517 g/mol (PubChem CID 71226662)
logP:3 (Drugs.Common 25.09, not verified)

Metabolites

ACP5862ACP-5862481.516 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
ACP5862metabolite: ACP-5862